H Yagita Selected Research

H Yagita Research Topics

Disease

19	Neoplasms (Cancer) 06/2013 - 01/2000
9	Inflammation (Inflammations) 09/2014 - 08/2000
6	Necrosis 01/2009 - 05/2001
5	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2015 - 04/2000
5	Leukemia 03/2013 - 08/2000
5	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 11/2012 - 01/2000
5	Autoimmune Diseases (Autoimmune Disease) 10/2007 - 01/2000
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 05/2006 - 03/2000
3	Asthma (Bronchial Asthma) 09/2014 - 01/2009
3	Neoplasm Metastasis (Metastasis) 11/2009 - 01/2001
3	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 01/2009 - 08/2006
3	Autoimmune Thyroiditis (Lymphomatous Thyroiditis) 12/2008 - 02/2001
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2015 - 04/2001
2	Hypersensitivity (Allergy) 07/2014 - 12/2001
2	Infections 05/2014 - 11/2000
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2013 - 12/2012
2	Colitis 10/2003 - 04/2003
2	Vasculitis (Vasculitides) 09/2002 - 11/2001
2	Pneumonia (Pneumonitis) 07/2001 - 04/2001
2	Glioma (Gliomas) 06/2001 - 03/2000
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2000 - 11/2000
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2016
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2016
1	Cytokine Release Syndrome 01/2015
1	Lung Diseases (Lung Disease) 05/2014
1	Respiratory Hypersensitivity 07/2013
1	Adenocarcinoma 06/2013
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 03/2013
1	Philadelphia Chromosome 03/2013
1	T-Cell Lymphoma (Lymphoma, T Cell) 02/2012
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2009
1	Melanoma (Melanoma, Malignant) 11/2009
1	Experimental Melanoma 11/2009
1	Synovitis 04/2008
1	Autoimmune Lymphoproliferative Syndrome 10/2007

Drug/Important Bio-Agent (IBA)

24	LigandsIBA 01/2016 - 03/2000
20	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016 - 08/2000
12	Monoclonal AntibodiesIBA 11/2009 - 03/2000
8	Fas Ligand Protein (Fas Ligand)IBA 10/2003 - 03/2000
7	CytokinesIBA 01/2015 - 04/2001
7	Interleukin-12 (IL 12)IBA 07/2013 - 01/2000
6	TNF-Related Apoptosis-Inducing LigandIBA 03/2013 - 11/2000
5	AntigensIBA 07/2014 - 03/2001
4	Death Domain ReceptorsIBA 03/2013 - 12/2006
3	Therapeutic UsesIBA 09/2014 - 04/2003
3	ChemokinesIBA 11/2009 - 08/2001
3	alpha-galactosylceramideIBA 10/2002 - 03/2001
3	OX40 LigandIBA 02/2001 - 01/2000
2	Proteins (Proteins, Gene)FDA Link 03/2015 - 01/2000
2	Fibrinolysin FDA Link 01/2015 - 02/2012
2	AllergensIBA 09/2014 - 07/2013
2	Immunoglobulin E (IgE)IBA 07/2014 - 09/2002
2	Immunoglobulins (Immunoglobulin)IBA 07/2014 - 11/2001
2	Immunoglobulin G (IgG)IBA 07/2014 - 03/2000
2	Neutralizing AntibodiesIBA 05/2014 - 02/2012
2	Myelin-Oligodendrocyte GlycoproteinIBA 11/2012 - 01/2000
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2012 - 03/2000
2	Matrix Metalloproteinases (MMPs)IBA 02/2012 - 11/2000
2	DNA (Deoxyribonucleic Acid)IBA 11/2009 - 03/2000
2	Thyroglobulin FDA Link 12/2008 - 12/2001
2	CaspasesIBA 01/2008 - 03/2000
2	NF-kappa B (NF-kB)IBA 01/2008 - 11/2001
2	AntibodiesIBA 12/2006 - 01/2000
2	InterleukinsIBA 12/2006 - 03/2001
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 09/2003 - 12/2001
2	Mercuric Chloride (Sublimate)IBA 09/2002 - 11/2001
2	InterferonsIBA 12/2001 - 03/2001
2	LipopolysaccharidesIBA 05/2001 - 11/2000
2	IntegrinsIBA 05/2001 - 04/2001
2	4-1BB Ligand (4 1BB Ligand)IBA 05/2001 - 12/2000
2	PerforinIBA 04/2001 - 01/2001
2	Peptides (Polypeptides)IBA 02/2001 - 01/2000
2	KB R7785IBA 11/2000 - 08/2000
1	SmokeIBA 01/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 06/2013
1	nilotinib FDA Link 03/2013
1	Imatinib Mesylate (Gleevec)FDA Link 03/2013
1	Small Interfering RNA (siRNA)IBA 03/2013
1	Dasatinib (BMS 354825)FDA Link 03/2013
1	Tyrosine Kinase InhibitorsIBA 03/2013
1	Stem Cell FactorIBA 02/2012
1	EnzymesIBA 02/2012
1	PlasminogenIBA 02/2012
1	Antifibrinolytic Agents (Antifibrinolytics)IBA 02/2012
1	Vaccine AdjuvantsIBA 11/2009
1	Chemokine CCL5IBA 11/2009
1	Complementary DNA (cDNA)IBA 11/2009
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 04/2008
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 04/2008
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2008
1	fas Receptor (CD95 Antigen)IBA 10/2007
1	Interleukin-10 (Interleukin 10)IBA 12/2006

Therapy/Procedure

9	Therapeutics 01/2016 - 01/2000
3	Immunotherapy 09/2014 - 12/2001
2	Stem Cell Transplantation 03/2013 - 12/2012
2	Transplantation 11/2012 - 05/2006
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 08/2000 - 04/2000
1	Oral Administration 07/2014
1	Aftercare (After-Treatment) 12/2006